Archive Newsletter

  1. 08.20.25 -- 5 Takeaways From The MHRA mRNA Guidance 8/20/2025
    08/20/25
  2. 08.13.25 -- Designing Effective Multivalent mRNA Therapies: Regulatory Considerations 8/13/2025

    08/13/25 Advancing RNA Newsletter

  3. 08.07.25 -- Best Practices For CROs In 2025 8/7/2025

    08/07/25 Advancing RNA Newsletter

  4. 07.31.25 -- Onshoring Biologics From Discovery To Commercial Drug Product 7/31/2025

    07/31/25 Advancing RNA Newsletter

  5. 07.30.25 -- What The EMA mRNA Guidance Means For The Industry 7/30/2025
    07/30/25 Advancing RNA Newsletter
  6. 07.24.25 -- Tools For Smarter Antibody Discovery 7/24/2025

    07/24/25 Advancing RNA Newsletter

  7. 07.23.25 -- The Art Of A Successful mRNA IND Submission 7/23/2025
    07/23/25 Advancing RNA Newsletter
  8. 07.21.25 -- Efficient And Scalable Preparative HPLC Solutions 7/21/2025
    07/21/25 Advancing RNA Newsletter
  9. 07.16.25 -- What Picasso Can Teach The mRNA Industry 7/16/2025
    07/16/25 Advancing RNA Newsletter
  10. 07.15.25 -- Innovation driving access in advanced therapies 7/15/2025

    07/15/25 Advancing RNA Newsletter